These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 17530461)

  • 1. RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases.
    Baud'huin M; Lamoureux F; Duplomb L; Rédini F; Heymann D
    Cell Mol Life Sci; 2007 Sep; 64(18):2334-50. PubMed ID: 17530461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease.
    D'Amelio P; Isaia G; Isaia GC
    J Endocrinol Invest; 2009; 32(4 Suppl):6-9. PubMed ID: 19724159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease.
    Kiechl S; Werner P; Knoflach M; Furtner M; Willeit J; Schett G
    Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):801-11. PubMed ID: 17173497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (review).
    Liu W; Zhang X
    Mol Med Rep; 2015 May; 11(5):3212-8. PubMed ID: 25572286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and Distribution of Receptor Activator of Nuclear Factor Kappa B, Receptor Activator of Nuclear Factor Kappa B Ligand, and Osteoprotegerin in Periradicular Cysts.
    Armada L; Marotta Pdos S; Pires FR; Siqueira JF
    J Endod; 2015 Aug; 41(8):1281-7. PubMed ID: 25956608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoimmunology: memorandum for rheumatologists.
    Zhao L; Huang L; Zhang X
    Sci China Life Sci; 2016 Dec; 59(12):1241-1258. PubMed ID: 27650950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the interaction between osteoprotegerin and receptor activator of NF-kappaB or tumor necrosis factor-related apoptosis-inducing ligand: evidence for a pivotal role for osteoprotegerin in regulating two distinct pathways.
    Vitovski S; Phillips JS; Sayers J; Croucher PI
    J Biol Chem; 2007 Oct; 282(43):31601-9. PubMed ID: 17702740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of T cell-associated tissues and T cell activation by RANKL-RANK-OPG.
    Walsh MC; Choi Y
    J Bone Miner Metab; 2021 Jan; 39(1):54-63. PubMed ID: 33438173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology.
    Hofbauer LC; Heufelder AE
    J Mol Med (Berl); 2001 Jun; 79(5-6):243-53. PubMed ID: 11485016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RANKL biology.
    Takegahara N; Kim H; Choi Y
    Bone; 2022 Jun; 159():116353. PubMed ID: 35181574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc supplements and bone health: The role of the RANKL-RANK axis as a therapeutic target.
    Amin N; Clark CCT; Taghizadeh M; Djafarnejad S
    J Trace Elem Med Biol; 2020 Jan; 57():126417. PubMed ID: 31653549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-20 differentially regulates bone mesenchymal stem cell activities in RANKL-induced osteoclastogenesis through the OPG/RANKL/RANK axis and the NF-κB, MAPK and AKT signalling pathways.
    Meng B; Wu D; Cheng Y; Huang P; Liu Y; Gan L; Liu C; Cao Y
    Scand J Immunol; 2020 May; 91(5):e12874. PubMed ID: 32090353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of the RANKL/RANK/OPG system.
    Yasuda H
    J Bone Miner Metab; 2021 Jan; 39(1):2-11. PubMed ID: 33389131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the RANK/RANKL/OPG system in the human intervertebral disc: implication for the pathogenesis of intervertebral disc degeneration.
    Sano T; Akeda K; Yamada J; Takegami N; Sudo T; Sudo A
    BMC Musculoskelet Disord; 2019 May; 20(1):225. PubMed ID: 31101043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Osteoprotegerin and Its Ligands in Vascular Function.
    Rochette L; Meloux A; Rigal E; Zeller M; Cottin Y; Vergely C
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30736365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives.
    Infante M; Fabi A; Cognetti F; Gorini S; Caprio M; Fabbri A
    J Exp Clin Cancer Res; 2019 Jan; 38(1):12. PubMed ID: 30621730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theoretical investigation of the role of the RANK-RANKL-OPG system in bone remodeling.
    Pivonka P; Zimak J; Smith DW; Gardiner BS; Dunstan CR; Sims NA; Martin TJ; Mundy GR
    J Theor Biol; 2010 Jan; 262(2):306-16. PubMed ID: 19782692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OPG/RANK/RANKL signaling system and its significance in nephrology.
    Klejna K; Naumnik B; Gasowska K; Myśliwiec M
    Folia Histochem Cytobiol; 2009; 47(2):199-206. PubMed ID: 19995704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The OPG/RANKL/RANK system and bone resorptive disease].
    Liu JZ; Ji ZL; Chen SM
    Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):655-60. PubMed ID: 15971575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical localization of RANK, RANKL and OPG in healthy and arthritic canine elbow joints.
    Spahni AI; Schawalder P; Rothen B; Bosshardt DD; Lang N; Stoffel MH
    Vet Surg; 2009 Aug; 38(6):780-6. PubMed ID: 19674422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.